Moderate riskFDA DrugClass II

Bionpharma divalproex sodium tablets recalled for foreign tablets

Bionpharma Inc. is recalling 500 mg divalproex sodium delayed-release tablets because the bottles have foreign tablets or capsules in them. No injuries have been reported. The recall covers one lot sold nationwide.

From the FDA notice · Read the official notice ↗

What to do

  1. Talk to your pharmacist or prescriber before stopping this medicine.
  2. Check the bottle for lot 704C003, expiration date 12/31/2028, and NDC 69452-435-30.
  3. The notice doesn't say how to get a refund or replacement; contact Bionpharma Inc. or the pharmacy where you bought it.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30.
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
N/A
Illnesses reported
None reported
Manufactured in
400 Alexander Park Ste 2-4b, N/A, Princeton, NJ, United States
Classification
Class II
Recall number
D-0742-2026

In the FDA's words

Description
Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500 Tablets bottles, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, Made in India, NDC 69452-435-30. Presence of Foreign Tablets/Capsules Lot# 704C003, Exp. 12/31/2028 Distribution: US Nationwide. Affected quantity: N/A
Hazard
Presence of Foreign Tablets/Capsules

More from Bionpharma

Related topics

OtherParticulateDrugsSold nationwideMore from FDA Drug